Please assess the completion status of the following clinical trial:

Trial Title: Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Manifest myopia between 1.00-4.00D in both eyes at screening visit~* Manifest astigmatism ≤2.50D; with-the-rule astigmatism (axes 180 ± 30) ≤2.50D; astigmatism with other axes ≤0.50D in both eyes at screening visit~* \<1.00D difference in manifest spherical equivalent (SE) between the two eyes at screening visit~* Baseline cycloplegic objective refraction between 1.00-4.00D in sphere; astigmatism ≤2.50D; \<1.00D difference in manifest SE between the two eyes~* Best-corrected logMAR visual acuity 0.10 or better in both eyes~* Symmetrical corneal topography with corneal toricity \<2.00D in either eye~* Normal ocular health other than myopia~* Agree to be randomized and to attend the scheduled visits and aftercare~Exclusion Criteria:~* Contraindications to atropine: known allergies or cardiovascular disease, epilepsy~* Contraindications to contact lens wear and ortho-k: corneal scar, history of ocular inflammation/infection, limbus-to-limbus corneal cylinder and dislocated corneal apex~* Strabismus or amblyopia~* History of myopia control treatment (e.g. soft contact lenses, progressive add spectacles, atropine eye drops)~* Rigid contact lens (including ortho-k) wear experience~* Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)~* Ocular conditions which might affect refractive error (for example, cataract, ptosis)~* Poor response to lens wear including poor lens handling, poor vision and/ocular response after lens modifications~* Poor compliance with schedule visits

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 11 Years
- Healthy Volunteers: t

Study Arms:
- ortho-k and 0.01% atropine eye drops (Type: EXPERIMENTAL): participants will receive treatment of ortho-k and 0.01% atropine eye drops
- ortho-k (Type: ACTIVE_COMPARATOR): participants will receive treatment of ortho-k alone

Based on this trial design, predict the completion outcome and termination type (if applicable).